Who was Barbara Mitchell?
  1. biologic medicine
  2. biologic medicine

biologic medicine

Octobre 29, 2020 12:02PM

Mandatory switching of biologic drugs—beware of potential side-effects
Yanick Labrie
Printer-friendly version
Mandatory switching of biologic drugs—beware of potential side-effects

Last year, British Columbia became the first province to introduce a mandatory biosimilar switching program for non-medical reasons.

Étiquettes:
biologic medicine, biosimilars, access to new drugs, access to new medicine
Juillet 9, 2020 1:00AM

Biologics and Biosimilars: A Primer
Kristina M.L. Acri, née Lybecker
Printer-friendly version
Biologics and Biosimilars: A Primer
Étiquettes:
biologics, biologic medicine, biosimilars, generic drugs, access to new medicine, pharmaceutical innovation, biotechnology
Juillet 12, 2016 4:27PM

Strengthening Canada’s intellectual property protections for biologic medicine may save lives
Kristina M.L. Acri, née Lybecker
Printer-friendly version
Biologic medicines, used to treat cancer and other maladies, are difficult and expensive to develop and manufacture.
Étiquettes:
biologics, drug production, medicine, intellectual property, biologic medicine, drug manufacture
Juillet 12, 2016 1:30AM

The Biologics Revolution in the Production of Drugs
Kristina M.L. Acri, née Lybecker
Printer-friendly version
Biologics Revolution in the Production of Drugs
Étiquettes:
biologics, drug production, medicine, intellectual property, biologic medicine, drug manufacture